U.S. market Closed. Opens in 10 hours 3 minutes

ARAY | Accuray Incorporated Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.7300 - 1.8200
52 Week Range 1.4000 - 3.05
Beta 0.89
Implied Volatility 252.50%
IV Rank 48.12%
Day's Volume 369,250
Average Volume 904,150
Shares Outstanding 100,274,000
Market Cap 180,493,200
Sector Healthcare
Industry Medical - Specialties
IPO Date 2007-02-08
Valuation
Profitability
Growth
Health
P/E Ratio -11.25
Forward P/E Ratio N/A
EPS -0.16
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 987
Country USA
Website ARAY
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
*Chart delayed
Analyzing fundamentals for ARAY we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ARAY Fundamentals page.

Watching at ARAY technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ARAY Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙